Peer-influenced content. Sources you trust. No registration required. This is HCN.
Dana-Farber Cancer Institute
With 40% of us expected to develop cancer in our lifetime and 20% likely to die from it, the need for advanced care is more urgent than ever. This collaboration between Dana-Farber and BIDMC represents a significant step towards meeting this need.
Oncology, Medical November 6th 2023
The New England Journal of Medicine
In addition to being stigmatized and vulnerable, people with intellectual or developmental disabilities are severely undercounted and underrepresented in medical research. This highlights the urgent need for more inclusive research and resources to ensure equitable cancer treatment for this population.
Internal Medicine November 1st 2023
Oncology News Central (ONC)
The proposed changes to the 2024 MPFS could have far-reaching implications for oncology care; stay informed to understand how these changes may impact your practice and patient outcomes.
Hematology/Oncology October 2nd 2023
The recent Stark Law interpretation has disrupted established medication delivery systems, posing a significant challenge for oncology practices. Learn how healthcare professionals are advocating for change and what alternative solutions are being explored.
Clinical Pharmacology October 2nd 2023
Ophthalmology Advisor
Understanding the ocular side effects of targeted cancer therapies is crucial. Early monitoring and interdisciplinary communication can significantly impact treatment outcomes.
Ophthalmology September 26th 2023
Learn how Olivia Kerins leverages her roles in healthcare and sports to fuel her passion for community service and education—offering a unique model for broad impact.
Nursing September 25th 2023